Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

The 68-year-old previously told how his diagnosis came as a 'real bolt from the blue' ...

NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with ...

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...

When I had my prostate removed in September 2023, I believed the worst was behind me. After months of tests, scans and ...

A study found that spop mutations increase prostate cancer sensitivity to ferroptosis, while chd1 deletions reduce ...

CHEYENNE – Cheyenne Regional Medical Center has successfully administered its first Pluvicto treatment, marking an important milestone for the organization's cancer program and expanding treatment opt ...

Hope for men with high-risk non-metastatic hormone resistant prostate cancerBy Dr Jacqueline Schmitt - Manager, Research ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...